| Bioactivity | Zolmitriptan (BW-311C90; 311C90) is a 5-HT1B/1D receptor partial agonist with Kis of 5.01 nM, 0.63 nM, and 63.09 nM for 5-HT1B, 5-HT1D, 5-HT1F receptor, respectively. Zolmitriptan can be used for the research of migraine[1][2]. | ||||||||||||
| Invitro | Zolmitriptan (311C90) exhibits higher affinity to 5-HT than sumatriptan (pKA=6.63±0.04 and 6.16±0.03, respectively). 311C90 displays high affinity at human recombinant 5-HT1D and 5-HT1B receptors in transfected CHO-K1 cell membranes (pIC50 values=9.16±0.12 and 8.32±0.09, respectively) [1]. | ||||||||||||
| Name | Zolmitriptan | ||||||||||||
| CAS | 139264-17-8 | ||||||||||||
| Formula | C16H21N3O2 | ||||||||||||
| Molar Mass | 287.36 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Zolmitriptan
CAS: 139264-17-8 F: C16H21N3O2 W: 287.36
Zolmitriptan (BW-311C90; 311C90) is a 5-HT1B/1D receptor partial agonist with Kis of 5.01 nM, 0.63 nM, and 63.09 nM for
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.